Core Insights - OneMedNet Corporation achieved record bookings of $2.79 million in 2025, exceeding 2024 bookings by more than four times, indicating strong enterprise demand and a shift towards a recurring subscription model [1][7]. Booking Highlights - Total bookings reached $2.79 million in contract value for 2025, which is 4.1 times higher than the previous fiscal year [7]. - The company is experiencing larger deal sizes due to the expansion of average contract value driven by enterprise-scale AI models and life sciences engagements [7]. - There is a continued shift towards subscription models, with agreements signed in 2025 with Circle CVI and mlHealth360, indicating a growing pipeline extending into 2026 [7]. Product Offerings - The company is diversifying its product mix, focusing on data projects and subscription products, including curated bespoke datasets and pre-curated specialty datasets for various therapeutic areas [8]. - Subscription offerings include Palantir Agentic Search for data discovery, which accelerates feasibility analysis from weeks to minutes, and near real-time streaming healthcare data feeds [8]. Strategic Positioning - OneMedNet is entering 2026 with a strong momentum and a high-quality pipeline anchored by premium recurring revenue solutions powered by Palantir Foundry [5]. - The company believes its subscription solutions will drive a more predictable, higher-margin, and scalable revenue profile as it transitions to a predominantly subscription-based business model [9]. Market Demand - There is sustained strong inbound demand for multimodal, regulatory-grade datasets, which serve as foundational entry points into longer-term subscription relationships [14]. - The adoption of AI-enabled discovery workflows is enhancing customer stickiness and creating multiple expansion opportunities within existing accounts [14].

Core Insights - OneMedNet Corporation has successfully delivered an anonymized Real-World Data feed representing 1.5 million patients and 4 million encounters to a healthcare data organization, marking a significant milestone in its subscription model [1][2][4] - The de-identified dataset contains over 1.49 billion datapoints, integrating comprehensive patient journeys and supporting advanced analytics and regulatory-grade research [2][4] - The company aims to transition customers to predictable annual recurring revenue streams, enhancing retention and long-term shareholder value [3][4] Company Overview - OneMedNet is focused on revolutionizing access to Real-World Data (RWD) through its iRWD™ platform, which taps into over 2,130 healthcare sites [5] - The company provides insights across various medical domains, including rare diseases, oncology, and cardiology, facilitating innovation for drugmakers and medical device companies [5] - Beyond healthcare, OneMedNet's AI technology anonymizes data for other industries such as finance and retail, showcasing its versatility [6]

Core Insights - OneMedNet Corporation is focused on enhancing its platform and executing its strategic plan to drive growth in 2026, highlighted by the integration of Palantir's AI platform for accelerated development [1][5][7] Financial Performance - The company reduced its total liabilities by approximately $19.6 million, achieving a 75% reduction by the end of 2025 compared to December 31, 2024 [5] - Third quarter bookings increased eightfold year-over-year from 2024 to 2025, indicating strong demand for Real-World Data (RWD) [5] Platform Development - OneMedNet is set to launch an AI-driven multimodal subscription search platform in the new year, which is expected to transform data interaction for life sciences organizations [1][5] - The iRWD™ platform integrates multiple data modalities, providing a comprehensive view of patient health and enabling real-time tracking of patient journeys [5][10] Market Trends - There is a growing demand for large-scale RWD to train, validate, and monitor AI models, alongside an increasing interest in long-term, subscription-based data relationships [5][13] - The traditional model of lengthy clinical trials is being disrupted as regulators encourage the use of Real-World Evidence (RWE) for regulatory approval and post-market surveillance [6][13] Strategic Initiatives - The company plans to expand its platform in 2026 by introducing additional services related to data cohort building and delivery, as well as solutions focused on Health Economics and Outcomes Research (HEOR) [5][13] - OneMedNet aims to address the critical bottleneck in accessing healthcare data, positioning itself to unlock the estimated $868 billion AI-driven healthcare market by 2030 [13]

Core Insights - OneMedNet Corporation has demonstrated significant engagement and commercial traction at the RSNA Annual Meeting, indicating strong interest from hospitals, imaging centers, and life sciences innovators in its iRWD™ platform powered by Palantir Foundry [1][2][5] Company Overview - OneMedNet is a leading provider of regulatory-grade, AI-ready Real-World Data (RWD) networks, leveraging over 2,130 healthcare sites to deliver insights that drive innovation in healthcare [6] - The company focuses on providing high-quality, multimodal datasets that support healthcare providers and life sciences organizations in research and product development [5][6] Market Validation - The RSNA 2025 event validated OneMedNet's strategy amid rising demand for regulatory-grade RWD, with healthcare providers expressing a strong interest in utilizing their clinical data assets [2][3] - Life sciences companies and AI developers showed keen interest in the next-generation iRWD™ platform, highlighting its capabilities in providing large-scale, high-fidelity datasets and AI-enabled cohort discovery [4][5] Strategic Partnerships - Healthcare providers are looking for reliable and low-effort ways to engage in healthcare innovation and research, while life sciences organizations require scalable datasets to accelerate product development [5] - OneMedNet's efficient deployment model and opportunities for compliant data sharing were noted as key advantages for potential partners [3][5]

Core Insights - OneMedNet Corporation has received strong validation for its redesigned data exploration and cohort-building platform from customers and prospects at ISPOR Europe, showcasing its commercial relevance and competitive differentiation [2][3] - The platform, built on Palantir Foundry and AIP, allows research teams to determine cohort feasibility in minutes instead of weeks, enhancing accuracy and efficiency [3][4] Company Overview - OneMedNet operates the largest global live, regulatory-grade AI-ready Real-World Data (RWD) network, encompassing over 2,130 provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images [2][4] - The company aims to revolutionize the use of Real-World Data, providing insights that drive innovation in drug development, medical devices, and AI applications [4][5] Technological Advancements - Key advancements of the new platform include significantly faster cohort feasibility, AI-driven natural-language search for complex discovery tasks, and real-time availability of longitudinal insights [7] - The platform supports subscription workflows, which is expected to contribute to recurring-revenue growth for the company [7]

Core Insights - OneMedNet Corporation has significantly expanded its iRWD™ network, enhancing its position as one of the largest live Real-World Data networks globally [1][2] - The company is experiencing momentum in its subscription model, which is crucial for capturing a share of the $60 billion Real-World Evidence market [2][3] Company Expansion - Approximately 380 new provider sites have been added, bringing the total to over 2,130, representing a 22% increase in network scale [6] - Unique de-identified patient records have increased by 13 million, totaling over 47 million, which is a 38% growth [6] - Clinical exams and images have expanded by 50 million, now exceeding 186 million, marking a 37% increase [6] Market Position - OneMedNet's subscription offerings are attracting pharmaceutical, life-science, and AI customers, leading to a virtuous cycle of increased commitments from existing subscribers and new long-term partnerships [2][3] - The company aims to leverage its extensive network to provide precise, diverse, and longitudinal cohorts, enhancing the value of its data feeds [2][3]

Core Insights - OneMedNet Corporation reported significant financial and operational progress in Q3 2025, highlighting a strong sales pipeline and increased demand for its AI-powered Real-World Data solutions [1][4]. Financial Highlights - Bookings reached $1.1 million in Q3 2025, representing an 815% increase compared to Q3 2024 [8]. - The company successfully completed an additional $0.5 million private placement of common stock, enhancing its strategic investment capabilities [8]. - OneMedNet improved its balance sheet by reducing total liabilities by $1.9 million in Q3, with a total reduction of $14.3 million year-to-date [8]. Operational Highlights - The integration of Palantir's AI Platform commenced in September 2025, enhancing the iRWD™ network with capabilities such as faster data discovery, AI-driven de-identification, and multimodal data integration [8]. - The rollout of a SaaS subscription model was announced, featuring Live Data Feeds and AI-Driven Conversational Search, transforming static data access into dynamic, on-demand intelligence [8]. - The company emphasized its focus on strategic opportunities to deliver long-term value, resulting in a 4.5X increase in inbound demand and larger deal sizes [4].

Core Insights - OneMedNet Corporation is set to showcase its next-generation iRWD™ platform at ISPOR Europe, which leverages the Palantir Technologies Foundry ecosystem to provide secure, regulatory-grade real-world data (RWD) through advanced AI analytics [1][3] - The company has introduced a recurring revenue model that enhances customer access to high-value RWD, featuring Live Data Feeds and AI-Driven Conversational Search, transforming static data access into dynamic, on-demand intelligence [2][7] - The healthcare sector is projected to present an estimated US$868 billion opportunity by 2030, with a significant challenge being the acquisition of high-quality, de-identified clinical multimodal data [3] Company Developments - OneMedNet's iRWD™ platform is designed to revolutionize the access and operationalization of real-world data from over 1,750 healthcare sites, providing insights that can drive innovation in drug development and patient care [4] - The platform's Live Data Feeds offer real-time streams of de-identified clinical data, while the AI-Driven Conversational Search allows users to query complex datasets using natural language, enhancing data accessibility and reducing technical barriers [7] Market Context - The AI-enabled market within healthcare is at a transformative inflection point, with responsible access to healthcare data being a key barrier to unlocking its full potential [3] - OneMedNet's collaboration with Palantir is expected to enhance its capabilities in delivering regulatory-grade, multimodal RWD with improved speed, consistency, and security [3]

Core Insights - OneMedNet Corporation has been selected by mlHealth360 as its Real-World Data provider, marking a significant milestone in the expansion of OneMedNet's subscription-based business model [1][2][3] Company Overview - OneMedNet is a leader in AI-powered Real-World Data (RWD), utilizing data from over 1,750 healthcare provider sites and 131 million+ clinical studies to support healthcare innovation [1][4] - The company’s iRWD™ platform provides regulatory-grade, de-identified imaging and clinical data, which is crucial for AI model development and validation [2][4] Partnership Details - The multi-year agreement with mlHealth360 allows continuous access to curated X-Ray and CT datasets, enhancing mlHealth360's capabilities in medical imaging [2][3] - The collaboration aims to improve patient care by providing high-quality medical imaging data, which is essential for advancing AI model development [3][6] Market Demand - There is a growing market demand for high-quality, multimodal Real-World Data that supports model training and regulatory-grade validation, highlighting the importance of partnerships with AI and analytics companies [3][4]

Core Insights - OneMedNet Corporation has partnered with Palantir Technologies to enhance the healthcare AI and Real-World Data analytics marketplace, utilizing Palantir's Artificial Intelligence Platform to support OneMedNet's iRWD™ near real-time AI powered provider network [1][2][4] Group 1: Partnership and Technology - The multi-year agreement allows Palantir's AI Platform to integrate with OneMedNet's network, which includes access to over 5 billion administrative claims and 131 million clinical exams from more than 1,750 provider sites [3] - Palantir's software aims to reduce costs and time to market for healthcare solutions, thereby improving patient outcomes [4][5] Group 2: Market Opportunity - Access to healthcare data is identified as a significant barrier to unlocking the projected $868 billion market opportunity in AI-driven healthcare by 2030 [2] - OneMedNet is positioned to leverage Palantir's advanced analytics to create scalable recurring revenue opportunities on a secure, regulatory-grade platform [2] Group 3: Operational Enhancements - The partnership will enable faster data discovery, allowing customer inquiries to be fulfilled in minutes, thus enhancing OneMedNet's competitive edge [9] - Features such as accurate data delivery, conversational search, and increased productivity through automation are expected to improve operational efficiency and reduce costs [9] Group 4: Data Security and Compliance - OneMedNet's proprietary AI algorithms will ensure the secure anonymization of clinical data, maintaining regulatory compliance and protecting against exposure of Protected Health Information (PHI) [9] - The integration of healthcare standards with Palantir's ontology will facilitate interoperable data access for life sciences users [9] Group 5: Broader Applications - Beyond healthcare, OneMedNet's AI capabilities are applicable in industries like finance, retail, and telecom, showcasing the versatility of its data anonymization technology [11]